Healthcare provider profile · identity verified

Malay Das, M.D

Internal Medicine · BRONX, NY · NPI 1295803120

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	538	204
Atorvastatin Calcium	Atorvastatin Calcium	536	208
Famotidine	Famotidine	411	120
Gabapentin	Gabapentin	375	115
Fluticasone Propionate	Fluticasone Propionate	371	115
Diclofenac Sodium	Diclofenac Sodium	344	132
Albuterol Sulfate Hfa	Albuterol Sulfate	286	79
Tamsulosin Hcl	Tamsulosin Hcl	246	93
Losartan Potassium	Losartan Potassium	236	94
Lisinopril	Lisinopril	235	88
Trazodone Hcl	Trazodone Hcl	222	56
Metoprolol Succinate	Metoprolol Succinate	213	74
Metformin Hcl	Metformin Hcl	205	83
Rosuvastatin Calcium	Rosuvastatin Calcium	194	77
Levothyroxine Sodium	Levothyroxine Sodium	185	76
Pravastatin Sodium	Pravastatin Sodium	169	65
Montelukast Sodium	Montelukast Sodium	144	67
Januvia	Sitagliptin Phosphate	140	48
Eliquis	Apixaban	135	38
Omeprazole	Omeprazole	133	46
Hydrochlorothiazide	Hydrochlorothiazide	130	48
Trulicity	Dulaglutide	127	39
Jardiance	Empagliflozin	118	45
Carvedilol	Carvedilol	109	43
Alendronate Sodium	Alendronate Sodium	108	31
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	105	35
Simvastatin	Simvastatin	97	28
Glimepiride	Glimepiride	94	30
Ammonium Lactate	Ammonium Lactate	93	22
Finasteride	Finasteride	93	30
Pioglitazone Hcl	Pioglitazone Hcl	93	39
Escitalopram Oxalate	Escitalopram Oxalate	90	21
Quetiapine Fumarate	Quetiapine Fumarate	87	22
Ozempic	Semaglutide	82	19
Diclofenac Sodium Er	Diclofenac Sodium	71	suppressed
Metformin Hcl Er	Metformin Hcl	66	30
Mirtazapine	Mirtazapine	64	25
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	61	22
Oxybutynin Chloride Er	Oxybutynin Chloride	58	16
Clopidogrel	Clopidogrel Bisulfate	56	24
Duloxetine Hcl	Duloxetine Hcl	55	18
Janumet	Sitagliptin Phos/Metformin Hcl	55	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	19
Donepezil Hcl	Donepezil Hcl	53	17
Metoprolol Tartrate	Metoprolol Tartrate	53	21
Pantoprazole Sodium	Pantoprazole Sodium	53	18
Alcohol Prep Pads	Alcohol Antiseptic Pads	52	24
Ibandronate Sodium	Ibandronate Sodium	52	16
Azelastine Hcl	Azelastine Hcl	50	15
Citalopram Hbr	Citalopram Hydrobromide	49	12
Doxepin Hcl	Doxepin Hcl	47	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	46	suppressed
Memantine Hcl	Memantine Hcl	46	12
Atenolol	Atenolol	42	14
Entresto	Sacubitril/Valsartan	42	11
Chlorthalidone	Chlorthalidone	41	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	12
Rybelsus	Semaglutide	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	40	16
Paroxetine Hcl	Paroxetine Hcl	38	15
Cilostazol	Cilostazol	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Calcitriol	Calcitriol	36	14
Hydralazine Hcl	Hydralazine Hcl	33	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	11
Trijardy Xr	Empaglifloz/Linaglip/Metformin	33	11
Single Use Swab	Alcohol Antiseptic Pads	32	12
Janumet Xr	Sitagliptin Phos/Metformin Hcl	31	suppressed
Lactulose	Lactulose	31	suppressed
Prednisone	Prednisone	31	17
Furosemide	Furosemide	29	13
Novolog Flexpen	Insulin Aspart	28	11
Repaglinide	Repaglinide	28	suppressed
Dulera	Mometasone/Formoterol	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Meloxicam	Meloxicam	24	13
Tradjenta	Linagliptin	24	11
Warfarin Sodium	Warfarin Sodium	24	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Levemir Flexpen	Insulin Detemir	21	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Risperidone	Risperidone	18	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Levemir	Insulin Detemir	17	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	12
Topiramate	Topiramate	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Procto-Med Hc	Hydrocortisone	14	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Prolia	Denosumab	12	suppressed
Torsemide	Torsemide	12	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	11	suppressed
Allopurinol	Allopurinol	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error